Feasibility and oncologic outcomes of minimally invasive surgery after induction chemoimmunotherapy for non–small cell lung cancerCentral MessagePerspective

Objective: We evaluated the feasibility and long-term outcomes of minimally invasive surgery (MIS) after neoadjuvant immunotherapy in patients with resectable non–small cell lung cancer (NSCLC). Methods: Patients with stage IB-IIIB NSCLC who underwent induction immunotherapy followed by surgery (201...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Giovanni M. Comacchio, MD, Marisa Sewell, MD, Kay See Tan, PhD, Nicolas Toumbacaris, MD, Matthew J. Bott, MD, Prasad S. Adusumilli, MD, Alexis Chidi, MD, PhD, Katherine Gray, MD, James Huang, MD, James M. Isbell, MD, Bernard J. Park, MD, Gaetano Rocco, MD, Valerie W. Rusch, MD, Smita Sihag, MD, David R. Jones, MD, Daniela Molena, MD
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2026-04-01
Rangatū:	JTCVS Open
Ngā marau:	minimally invasive surgery induction therapy immunotherapy non–small cell lung cancer
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S266627362600046X
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!